References
- Barnes D, Dick A L, Hadley H L, et al. Survival following transurethral resection of bladder carcinoma. Cancer Res 1977; 37: 2895–2897
- Barnes R, Hadley H L, Dick A L, et al. Changes in grade and stage of recurrent bladder tumors. J Urol 1977; 118: 117–118
- Baurain R, Masquelier M, Peterson C, et al. Quantitative determination of intracellular concentrations of daunorubicin and adriamycin and their main metabolites by high‐pressure liquid chromatography. Current chemotherapy. Proc 10th Int Congr Chemother 1978; 11: 1130
- Calais da Silva F, Denis L, Bona A, et al. Intravesical chernoresection with 4′‐Epi‐Doxorubicin in patients with superficial bladder tumours. Eur Urol 1988; 14: 207–209
- Cersosimo R J, Hong W K. Epirubicin: A review of the pharmacology, clonical activity and reverse effects of an adriamycin analogue. J Clin Oncol 1986; 4: 425–439
- Jacobi G H. Topische intravesikale Anwendung von Chemotherapeutika beim Übergangsepitheltumor der Harnblase. I. Adjuvante Rezidivchernoprophylaxe. Terapiewoche 1979; 29: 5954–5959
- Jones H C, Swinney J. Thio‐Tepa in the treatment of tumours of the bladder. Lancet 1961; 2: 615–618
- Lowry O M, Rosebrough N J, Farr A L, et al. Protein measurement with folin phenol reagent. Biol Chem 1951; 193: 265–267
- Matsumura Y, Tsushima T, Ozaki Y, et al. Intravesical chemotherapy with 4′‐Epi‐Adriamycin in patients with superficial bladder tumors. Cancer Chemother Pharmacol 1986; 16: 176–177
- Prout G R, Jr, Koontz W W, Jr, Coomps L J, et al. National Bladder Cancer Collaborative Group A: Long term fate of 90 patients with superficial bladder cancer randomly assigned to receive or not to receive thiotepa. J Urol 1983; 130: 677–690
- Rübben H, Dahm H H, Lutzeyer W. Rezidivhäufigkeit und Tumorprogression superficiale Harnblasen‐karzinome. Urologe A 1981; 20: 211–214
- Salto K, Fukushima S, Takahashi Y, et al. The recurrence after conservative therapy of bladder tumor. Jpn J Urol 1980; 71: 449–452
- Simpson W G, Tseng M T, Anderson K C, et al. Verapamil enhancement of chemotherapeutic efficacy in human bladder cancer cells. J Urol 1984; 132: 574–576
- Soloway M S. Rationale for intensive intravesical chemotherapy for superficial bladder cancer. J Urol 1980; 123: 461–466
- Tamassia V. Human pharmacokinetics of epirubicin. 14th International Cancer Congress. August, 21–271986. BudapestHungary, 9: 81–84
- Tidefelt U, Sundman‐Engberg B, Paul C. Effects of verapamil on uptake and in vitro toxicity of anthracyclines in human leukemic blast cells. Eur J Haematol 1988; 40: 385–395
- Tsuruo T, Iida H, Tsukagoshi S, et al. Increased accumulation of vincristine and adriamycin in drug‐resistence P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res 1982; 42: 4730–4733